Literature DB >> 8101586

Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue.

A Feliciello1, A Porcellini, I Ciullo, G Bonavolontà, E V Avvedimento, G Fenzi.   

Abstract

It is not clear whether the ophthalmopathy present in Graves' disease is related to autoimmune reactions to common thyroid/orbit components or is due to specific ocular antigens unrelated to the thyroid. In Graves' disease, serum antibodies to the thyrotropin receptor (TSH-R) can stimulate thyroid function, but no link between the TSH-R and ocular tissues has been found. We have shown, by polymerase chain reaction amplification of specific cDNA, that mature TSH-R mRNA is expressed in the retro-orbital tissue of both healthy subjects and patients with Graves' disease. Of other tissues and cells tested (fibroblasts, lymphocytes, muscle, and thyroid), only thyroid tissue expressed the TSH-R mRNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101586     DOI: 10.1016/0140-6736(93)91475-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  69 in total

Review 1.  Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease.

Authors:  M Ludgate; G Baker
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Radioiodine is an effective, inexpensive, and safe treatment for Graves' hyperthyroidism, its immunological effects must be taken into account.

Authors:  L Chiovato; R Rocchi; E Fiore
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

3.  Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.

Authors:  Annamaria De Bellis; Giovanni Conzo; Gilda Cennamo; Elena Pane; Giuseppe Bellastella; Caterina Colella; Assunta Dello Iacovo; Vanda Amoresano Paglionico; Antonio Agostino Sinisi; Jack R Wall; Antonio Bizzarro; Antonio Bellastella
Journal:  Endocrine       Date:  2011-11-16       Impact factor: 3.633

Review 4.  Novel aspects of orbital fibroblast pathology.

Authors:  T J Smith
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

5.  Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

Authors:  Terry J Smith; Dolly A Padovani-Claudio; Ying Lu; Nupur Raychaudhuri; Roshini Fernando; Stephen Atkins; Erin F Gillespie; Andrew G Gianoukakis; Barbra S Miller; Paul G Gauger; Gerard M Doherty; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

Review 6.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 7.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

8.  Disrupted TSH Receptor Expression in Female Mouse Lung Fibroblasts Alters Subcellular IGF-1 Receptor Distribution.

Authors:  Stephen J Atkins; Stephen I Lentz; Roshini Fernando; Terry J Smith
Journal:  Endocrinology       Date:  2015-09-21       Impact factor: 4.736

9.  Thyrotropin-independent induction of thyroid endoderm from embryonic stem cells by activin A.

Authors:  Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Endocrinology       Date:  2008-12-12       Impact factor: 4.736

10.  A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.

Authors:  Seema Kumar; Reagan Schiefer; Michael J Coenen; Rebecca S Bahn
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.